Fitzgerald Kevin Joseph bought ALNY
November 17, 2025 · Form 4 insider transaction
Fitzgerald Kevin Joseph bought 8,161 shares of Alnylam Pharmaceuticals, Inc. at $119.13 per share, a transaction worth $972.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,161
Price
$119.13
Total value
$972.2K
InsiderFitzgerald Kevin Joseph
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after33,392
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the Reporting Person on August 14, 2025.